Ciphergen Biosystems

About:

Ciphergen Biosystems is focused on the discovery, development and commercialization of high-value, molecular diagnostic products.

Top Investors: Bio-Rad Laboratories, Morgan Stanley Expansion Capital, Amadeus Capital Partners

Description:

Ciphergen Biosystems, Inc. is focused on the discovery, development and commercialization of high-value, molecular diagnostic products to improve patient care. Ciphergen, along with its prestigious scientific collaborators, has ongoing diagnostic programs primarily in oncology with an initial focus in ovarian and prostate cancer. Based in Fremont, California

Total Funding Amount:

$32M

Headquarters Location:

Fremont, California, United States

Founded Date:

Founders:

Number of Employees:

Last Funding Date:

2006-08-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai